General

New medicines supply Agreement to improve patients’ access to innovative new treatments

A new supply Agreement between the research-based biopharmaceutical industry and the State will improve patients’ access to the latest innovative medicines.

latest innovative medicines, according to the Irish Pharmaceutical Healthcare Association

A new supply Agreement between the research-based biopharmaceutical industry and the State will improve patients’ access to the latest innovative medicines. This is according to the Irish Pharmaceutical Healthcare Association, the representative organisation for medicines innovators.

Four-year Agreement reached between international research-based biopharmaceutical industry and the State

For verified healthcare professionals

Log in or register for free to read this article. HPN is for healthcare professionals, so new accounts are verified by our team.

Register for free Log in

Join the conversation

Comments are open to registered members. Log in or register to share your thoughts on this article.

Log in to comment Register for free